Indonesia hosts conference on typhoid, Invasive NTS Disease

Indonesia hosted a conference on typhoid and Invasive NTS Disease over the weekend.
Indonesia hosted a conference on typhoid and Invasive NTS Disease over the weekend. | Courtesy of
Bali, Indonesia, hosted the 9th International Conference on Typhoid and Invasive NTS Disease, hosted by Bio Farma and the Coalition against Typhoid (CaT), over the weekend.

Experts estimate that typhoid infects approximately 21 million people around the world annually, killing more than 216,000. Most who die are under 15 years old.

Experts also estimate that iNTS infects approximately 3.4 million people each year, leading to 681,316 deaths.

Over 200 health professionals from around the world attended the conference. For three days, these public health leaders discussed various strategies to battle typhoid, as well as invasive non-typhoidal salmonella (iNTS) disease.

 Several health officials presented their most recent research on these two diseases, recommendations for global policies concerning iNTS, and intervention strategies that are more cost effective.

"Every child deserves the chance to live a healthy and productive life," Dr. Mohamad Subuh, director general of disease control and enviromental health at the Indonesian Ministry of Health, said. "In many countries in Asia and Africa, (iNTS) remains a public health concern. We need to work together to improve diagnostic tools, develop efficacious vaccines and make treatment more accessible for vulnerable communities around the world."

“Vaccines provide an immediate solution to the human suffering caused by typhoid," Imran Khan, director of the CaT Secretariat at the U.S.-based Sabin Vaccine Institute, said. "We have made significant progress since the last international conference on typhoid in 2013 in Dhaka, Bangladesh. Two conjugate vaccines have been licensed in India, and six more are in clinical development and will be licensed in their country of manufacture by 2018. To continue this momentum, the Coalition against Typhoid will work with partners on the critical next steps: securing a revised immunization policy and financial commitment for typhoid conjugate vaccines."

Organizations in this Story

Bio Farma

Want to get notified whenever we write about Bio Farma ?
Next time we write about Bio Farma, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.